JP2013537426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537426A5 JP2013537426A5 JP2013524945A JP2013524945A JP2013537426A5 JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5 JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- cancer
- item
- orf3
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37421510P | 2010-08-16 | 2010-08-16 | |
| US61/374,215 | 2010-08-16 | ||
| PCT/US2011/048005 WO2012024350A2 (en) | 2010-08-16 | 2011-08-16 | Anti-cancer adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537426A JP2013537426A (ja) | 2013-10-03 |
| JP2013537426A5 true JP2013537426A5 (cg-RX-API-DMAC7.html) | 2014-09-18 |
| JP5905460B2 JP5905460B2 (ja) | 2016-04-20 |
Family
ID=45605646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524945A Active JP5905460B2 (ja) | 2010-08-16 | 2011-08-16 | 抗がんアデノウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9187733B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2606137B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5905460B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101667094B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103180448B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011292119B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013003579A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2807778C (cg-RX-API-DMAC7.html) |
| SG (1) | SG187785A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012024350A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012024350A2 (en) * | 2010-08-16 | 2012-02-23 | Salk Institute For Biological Studies | Anti-cancer adenoviruses |
| AU2013232101B2 (en) * | 2012-03-13 | 2018-01-04 | Salk Institute For Biological Studies | Selective cell targeting using adenovirus and chemical dimers |
| KR102089121B1 (ko) | 2013-03-14 | 2020-03-13 | 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양살상형 아데노바이러스 조성물 |
| WO2017062511A1 (en) | 2015-10-05 | 2017-04-13 | Salk Instutitute For Biological Studies | Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration |
| KR20180112024A (ko) | 2016-02-23 | 2018-10-11 | 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 바이러스 동역학에 미치는 영향 최소화를 위한 치료용 아데노바이러스의 외인성 유전자 발현 |
| CA3013637A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| CN110612116A (zh) | 2017-05-08 | 2019-12-24 | 磨石肿瘤生物技术公司 | 甲病毒新抗原载体 |
| AU2019251356B2 (en) | 2018-04-09 | 2025-06-12 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions with enhanced replication properties |
| TW202523847A (zh) * | 2019-05-30 | 2025-06-16 | 美商磨石生物公司 | 經修飾之腺病毒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA137094A (en) | 1911-08-31 | 1911-11-28 | Sheppe, Alice L. | Cloth measuring and price calculating machine |
| FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
| DE69914382T2 (de) * | 1998-07-07 | 2004-11-04 | Transgene S.A. | Verwendung der Leserahmen der adenoviralen E4-Region zur Verbesserung der Genexpression |
| EP1083229A1 (en) * | 1999-09-10 | 2001-03-14 | Introgene B.V. | Modified adenoviral vectors for use in gene therapy |
| AU5882801A (en) * | 2000-05-26 | 2001-12-03 | Sumitomo Pharmaceuticals Company, Limited | Novel recombinant adenovirus vector with relieved side effects |
| US20020106382A1 (en) * | 2000-07-14 | 2002-08-08 | Young Charles S.H. | Modified adenovirus and uses thereof |
| US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
| EP1499332A4 (en) | 2002-04-29 | 2006-12-06 | Hadasit Med Res Service | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH A VIRAL ONCOLYTIC AGENT |
| US20060099709A1 (en) | 2002-10-01 | 2006-05-11 | Chuan-Yuan Li | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| US20050201978A1 (en) | 2003-11-17 | 2005-09-15 | Lipton James S. | Tumor and infectious disease therapeutic compositions |
| EP2352516A2 (en) * | 2008-09-26 | 2011-08-10 | Auburn University | Immunization of avians by mucosal administration of non-replicating vectored vaccines |
| WO2012024350A2 (en) * | 2010-08-16 | 2012-02-23 | Salk Institute For Biological Studies | Anti-cancer adenoviruses |
-
2011
- 2011-08-16 WO PCT/US2011/048005 patent/WO2012024350A2/en not_active Ceased
- 2011-08-16 SG SG2013009790A patent/SG187785A1/en unknown
- 2011-08-16 CN CN201180050032.7A patent/CN103180448B/zh active Active
- 2011-08-16 EP EP11818698.0A patent/EP2606137B1/en active Active
- 2011-08-16 KR KR1020137006526A patent/KR101667094B1/ko active Active
- 2011-08-16 AU AU2011292119A patent/AU2011292119B2/en active Active
- 2011-08-16 JP JP2013524945A patent/JP5905460B2/ja active Active
- 2011-08-16 BR BR112013003579A patent/BR112013003579A2/pt not_active Application Discontinuation
- 2011-08-16 CA CA2807778A patent/CA2807778C/en active Active
-
2013
- 2013-02-15 US US13/768,933 patent/US9187733B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537426A5 (cg-RX-API-DMAC7.html) | ||
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| MY183703A (en) | Oncolytic adenovirus encoding a b7 protein | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| WO2012142529A3 (en) | Clonal strains of attenuated vaccinia viruses and methods of use thereof | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| FR2981643B1 (fr) | Procede de preparation d'un materiau composite silicium/carbone, materiau ainsi prepare, et electrode notamment electrode negative, comprenant ce materiau. | |
| NZ748120A (en) | Tri-segmented pichinde viruses as vaccine vectors | |
| BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
| JP2018512047A5 (cg-RX-API-DMAC7.html) | ||
| MX360045B (es) | Combinaciones farmacéuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf. | |
| JP2011157399A5 (cg-RX-API-DMAC7.html) | ||
| BR112018074869A2 (pt) | anticorpos antagonistas que ligam t ao tgfb1, tgfb2 e ao tgfb3 humanos e seu uso para o tratamento de fibrose pulmonar | |
| PH12014500865A1 (en) | Compounds and methods for enhancing innate immune responses | |
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| MA39096B1 (fr) | Anticorps spécifiques à fcrn | |
| WO2018083220A3 (en) | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines | |
| BR112014029338A2 (pt) | biomarcadores para determinação da resposta eficaz dos tratamentos de pacientes com carcinoma hepatocelular (hcc) | |
| JP2018512597A5 (cg-RX-API-DMAC7.html) | ||
| MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
| JP2013544892A5 (cg-RX-API-DMAC7.html) | ||
| Hu et al. | Oncolytic viruses for the treatment of bladder cancer: advances, challenges, and prospects | |
| JP2015044878A5 (cg-RX-API-DMAC7.html) | ||
| JP2013100370A5 (cg-RX-API-DMAC7.html) | ||
| Du et al. | Adenovirus-mediated expression of Bm K CT suppresses growth and invasion of rat C6 glioma cells |